Skip to main content
. 2020 Nov 19;14(1):16. doi: 10.3892/br.2020.1392

Table I.

Anti-cytokine based therapeutic options for treatment of rheumatoid arthritis.

Anti TNF-α agents Anti IL-1 agent Anti IL-6 agent
Infliximab Anakinra Tocilizumab
Etanercept    
Adalimumab    
Certolizumab    
Golimumab    

IL, interleukin; TNF-α, tumor necrosis factor-α.